Denali Therapeutics Financial Overview
Denali Therapeutics's market cap is currently $2.64B. The company's EPS TTM is $-0.74; its P/E ratio is ―; Denali Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.
